The Latest Breaking News from Johnson & Johnson (

Despite Johnson & Johnson’s relative underperformance over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

The healthcare industry is set for growth due to the growing demand for quality healthcare services and the aging population. Hence, quality healthcare stocks, such as Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck & Co. (MRK), might be worth looking into. Read more….

The World Health Organization's cancer agency on Friday classified talc as "probably carcinogenic" for humans, however an outside expert warned against misinterpreting the announcement as a "smoking gun".

Looking for income this summer? Here are three quality companies that'll put a few extra dollars in your pocket.

Patience helped these four investors make their portfolios work for them.

Blue-chip companies, characterized by large capitalization, global footprint, solid financial performance, robust balance sheet, and dominant market position, are favored by investors seeking stability and long-term growth potential. Thus, quality blue-chip stocks Microsoft (MSFT), Procter & Gamble (PG), and Johnson & Johnson (JNJ) could be attractive buys for steady returns.…

Pharmaceutical giant’s payout settles allegations it misled consumers about safety of its talcum-based powder products.

The pharmaceutical sector is experiencing rapid growth thanks to the rising demand for precision drugs, the growing geriatric population, and an uptick in chronic diseases. Given this backdrop, long-term value investors could consider buying and holding quality pharmaceutical stocks such as Organon (OGN), Procaps (PROC), Johnson & Johnson (JNJ), and…

Johnson & Johnson faces legal action over alleged fraudulent bankruptcies related to talc products causing cancer.